(PRESS RELEASE) BUCHAREST, Romania, 18-Mar-2019 — /EuropaWire/ — We would like to inform the market and our investors that today, 18 March 2019, Mr. Sambor Ryszka, one of the non-executive directors of the Company, decided to resign from his position. … Read the full press release
Posted in Business, Financial, Investment, Law, Management, Media, News, Romania, Technology, Telecom
Tagged AFM, Android TV-based entertainment service, article 82 of Law no. 24/2017, ASF, Bucharest Stock Exchange, buy back shares, buy-back program, BVB, Class A shares, Class B shares, conference call, Digi, Digi Communications, Digi Communications 2018 Preliminary financial results, Digi Communications Conference Call, Digi Communications NV, DIGI symbol, directors stock option plans, Dutch Authority for the Financial Markets, employees stock option plans, equity reserves, Euronext Dublin, financial transactions, FSA Regulation no. 5/2018, Hungary, Investor Relations, investors, IPO, Irish Stock Exchange, market, mobile services, MVNO, Non-Executive Director, Regulation, resignation, Romania, Romanian Financial Supervisory Authority, Romanian National Securities Commission, romanian telecommunications provider, Sambor Ryszka, Securities, senior secured notes, Serghei Bulgac, shareholders, shares, shares buy-back, shares conversion, Spain, stock option plans, Telecom Market, TELECOMMUNICATION PROVIDER, telecommunications, telecommunications services, trading, transactions, tv
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
